However, as we observed in our in vitro results, B7-H3 CAR T cell treatment was more effective in eradicating ATC tumors and prolonging mice survival (Fig. 5D), confirming the superiority of B7-H3 as target tumor antigen in ATC. Here, CD276 is linked to neoplasm.